What is the recommended dose and treatment duration of valacyclovir (an antiviral medication) for an adult patient with a normal immune system and diagnosed with herpes simplex or herpes zoster?

Valacyclovir Dosing for Herpes Simplex and Herpes Zoster in Immunocompetent Adults

Herpes Zoster (Shingles)

For herpes zoster in immunocompetent adults, valacyclovir 1000 mg three times daily for 7 days is the recommended regimen, initiated within 72 hours of rash onset and continued until all lesions have completely scabbed. 1, 2

Standard Treatment Protocol

• Dosing: Valacyclovir 1000 mg orally three times daily (every 8 hours) 1, 2, 3
• Duration: 7 days minimum, but treatment must continue until all lesions have completely scabbed—this is the critical clinical endpoint, not an arbitrary calendar duration 1
• Timing: Initiate within 72 hours of rash onset for optimal efficacy, though treatment started after 72 hours may still provide benefit for pain reduction 1, 4

Key Clinical Advantages

• Valacyclovir significantly accelerates resolution of zoster-associated pain compared to acyclovir (median 38 days vs 51 days) and reduces postherpetic neuralgia duration 3
• The three-times-daily dosing offers better adherence than acyclovir's five-times-daily regimen while maintaining superior pain control 1, 3
• Cutaneous lesion healing rates are equivalent between valacyclovir and acyclovir 4, 3

Renal Dose Adjustments

For patients with renal impairment, adjust dosing as follows 2:

• CrCl 30-49 mL/min: 1000 mg every 12 hours
• CrCl 10-29 mL/min: 1000 mg every 24 hours
• CrCl <10 mL/min: 500 mg every 24 hours

---

Herpes Simplex Infections

Recurrent Genital Herpes (Episodic Treatment)

For recurrent genital herpes episodes, valacyclovir 500 mg twice daily for 5 days initiated at the first sign of prodrome or lesions is the standard regimen. 5, 2

• Dosing: 500 mg orally twice daily 5, 2
• Duration: 5 days 5, 2
• Critical timing: Must be initiated at first sign of prodrome (tingling, itching, burning) or within 24 hours of lesion onset for maximum efficacy 6, 5
• Patient counseling: Provide prescription in advance so treatment can begin immediately when symptoms appear 6, 5

Cold Sores (Herpes Labialis)

For cold sores in adults and adolescents ≥12 years, valacyclovir 2000 mg twice daily for 1 day (two doses 12 hours apart) is the recommended short-course regimen. 6, 2

• Dosing: 2000 mg (2 grams) twice daily, 12 hours apart 6, 2
• Duration: Single day (total of 2 doses) 6, 2
• Timing: Initiate during prodromal phase or within 24 hours of symptom onset, as peak viral titers occur in the first 24 hours 6
• Efficacy: Reduces median episode duration by 1.0 day compared to placebo 6

Suppressive Therapy for Frequent Recurrences

For patients with ≥6 recurrences per year, valacyclovir 500-1000 mg once daily provides effective suppression, reducing recurrence frequency by ≥75%. 6, 5

• Standard dose: 1000 mg once daily for most patients 6, 5, 7
• Alternative dose: 500 mg once daily for patients with ≤9 recurrences per year 6, 2
• Duration: Safety documented for 1 year of continuous use; reassess recurrence rate after 1 year by discontinuing therapy 6
• Important caveat: Suppressive therapy reduces but does not eliminate asymptomatic viral shedding—transmission can still occur 6, 5

First Episode Genital Herpes

• Dosing: Valacyclovir 1000 mg twice daily 8
• Duration: 10 days 8
• Efficacy: Equivalent to acyclovir 200 mg five times daily in reducing viral shedding, hastening lesion healing, and decreasing pain 9, 8

---

Critical Clinical Considerations

When to Escalate to Intravenous Acyclovir

Switch to IV acyclovir 5-10 mg/kg every 8 hours for: 1, 5

• Disseminated herpes zoster (multi-dermatomal or visceral involvement)
• CNS complications
• Severe ophthalmic disease with suspected CNS involvement
• Any severe HSV or VZV infection requiring hospitalization

Common Pitfalls to Avoid

• Do not stop treatment at exactly 7 days for herpes zoster if lesions have not completely scabbed—continue until all lesions are crusted 1
• Do not use topical antivirals as primary therapy—they are substantially less effective than systemic therapy and cannot reach sites of viral reactivation 1, 6
• Do not delay treatment waiting for laboratory confirmation in typical presentations—initiate immediately based on clinical diagnosis 1
• Do not use short-course genital herpes regimens for herpes zoster—VZV requires higher doses and longer duration than HSV 1

Renal Monitoring

• Monitor renal function at treatment initiation and during therapy, particularly with IV acyclovir 1
• Ensure adequate hydration to prevent acyclovir-induced nephrotoxicity 1
• Adjust doses based on creatinine clearance as outlined above 2

Tolerability Profile

• Valacyclovir is well tolerated with adverse events similar to acyclovir or placebo 7, 9, 4, 3
• Most common side effects: headache (<10%), nausea (<4%), and diarrhea (typically mild to moderate) 6
• Critical warning: Do not use valacyclovir 8 grams per day in immunocompromised patients due to risk of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome 5, 7

Resistance Considerations

• Acyclovir resistance remains rare in immunocompetent patients (<0.5%) 6
• All acyclovir-resistant strains are also resistant to valacyclovir 5
• For confirmed resistance, switch to IV foscarnet 40 mg/kg every 8 hours 1, 5